Show simple item record

dc.contributor.authorIqbal, MS
dc.contributor.authorWarner, L
dc.contributor.authorPaleri, V
dc.contributor.authorKovarik, J
dc.contributor.authorKelly, C
dc.date.accessioned2021-05-20T13:34:38Z
dc.date.available2021-05-20T13:34:38Z
dc.date.issued2020-06-01
dc.identifier.citationOral oncology, 2020, 105 pp. 104768 - ?
dc.identifier.issn1368-8375
dc.identifier.urihttps://repository.icr.ac.uk/handle/internal/4570
dc.identifier.eissn1879-0593
dc.identifier.doi10.1016/j.oraloncology.2020.104768
dc.formatPrint-Electronic
dc.format.extent104768 - ?
dc.languageeng
dc.language.isoeng
dc.publisherELSEVIER
dc.rights.urihttps://www.rioxx.net/licenses/all-rights-reserved
dc.subjectHumans
dc.subjectPapillomaviridae
dc.subjectPapillomavirus Infections
dc.subjectCarcinoma
dc.subjectOropharyngeal Neoplasms
dc.subjectAlphapapillomavirus
dc.subjectPatient Preference
dc.subjectCOVID-19
dc.subjectSARS-CoV-2
dc.titleDe-intensification of treatment in human papilloma virus related oropharyngeal carcinoma: Patient choice still matters for de-escalation and for the COVID era.
dc.typeJournal Article
dcterms.dateAccepted2020-04-29
rioxxterms.versionVoR
rioxxterms.versionofrecord10.1016/j.oraloncology.2020.104768
rioxxterms.licenseref.urihttps://www.rioxx.net/licenses/all-rights-reserved
rioxxterms.typeJournal Article/Review
dc.relation.isPartOfOral oncology
pubs.notesNot known
pubs.organisational-group/ICR
pubs.organisational-group/ICR/Primary Group
pubs.organisational-group/ICR/Primary Group/Royal Marsden Clinical Units
pubs.organisational-group/ICR
pubs.organisational-group/ICR/Primary Group
pubs.organisational-group/ICR/Primary Group/Royal Marsden Clinical Units
pubs.publication-statusPublished
pubs.volume105
pubs.embargo.termsNot known
dc.contributor.icrauthorPaleri, Vinidh


Files in this item

Thumbnail

This item appears in the following collection(s)

Show simple item record